'Struc­ture, beau­ty and clar­i­ty': With seed fi­nanc­ing, Kalei­do­scope aims to syn­chro­nize R&D teams

High school friends Bog­dan Kneze­vic and Ahmed El­naiem kept in touch in the years fol­low­ing grad­u­a­tion, and about a decade lat­er found them­selves hop­ping on calls every week to “catch up and riff on things.”

Kneze­vic, af­ter work­ing on a clin­i­cal med­i­cine PhD at Ox­ford and tak­ing a sum­mer stint at Fre­quen­cy Ther­a­peu­tics, be­came an­noyed by the siloed na­ture of drug R&D.

“The crux of my frus­tra­tion was the amount of time I was wast­ing and spend­ing not do­ing sci­ence,” Kneze­vic told End­points News, speak­ing of his vent­ing-and-catch­ing-up calls with El­naiem, who’d been work­ing his way through mul­ti­ple prod­uct en­gi­neer­ing roles at a se­ries of star­tups and Google.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER